Spencer Pharmaceutical Inc. Announcement Related to Proof of Funds
2011年2月1日 - 7:30AM
Marketwired
(PINKSHEETS: SPPH) Management of Spencer Pharmaceutical Inc.
announced that the Company has received from an investment group
mandated by His Excellency Hussain Al-Awaid (Al-Dorra group)
confirmation of their intent to prepare availability of funds for
the proposed buy-out of Spencer. The release of funds is subject to
completion of due diligence and preparation of final documentation.
Specific time-frame has not changed as per the original parameters
previously disclosed in press releases on December 10th, and 14th,
2010 respectively.
About Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. is a US based Pharmaceutical
Research and Development Corporation, which is developing
innovative drug release and absorption systems for the treatment of
metabolic diseases such as diabetes and metabolic syndrome.
Important Information
About Forward-Looking Statements in this
press release may be "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Words such as "anticipate," "believe," "estimate," "expect,"
"intend" and similar expressions, as they relate to the company or
its management, identify forward-looking statements. These
statements are based on current expectations, estimates and
projections about the company's business based, in part, on
assumptions made by management. These statements are not guarantees
of future performance and involve risks, uncertainties and
assumptions that are difficult to predict. Therefore, actual
outcomes and results may, and probably will, differ materially from
what is expressed or forecasted in such forward-looking statements
due to numerous factors, including those described above. In
addition, such statements could be affected by risks and
uncertainties related to the exploration for and development of
mineralized material, product demand, market and customer
acceptance, competition, pricing and development difficulties, as
well as general industry and market conditions and growth rates and
general economic conditions. Any forward-looking statements speak
only as of the date on which they are made, and the company does
not undertake any obligation to update any forward-looking
statement to reflect events or circumstances after the date of this
release. Information on the Company's website does not constitute a
part of this release. As the offer will be coming from a third
party, the Company can provide no assurances that the offer will be
made, the timelines achieved, or the minimum offer will be
realized.
Contact: Ian Morrice Executive VP and Director Spencer
Pharmaceutical Inc. 1+(617) 973-5017
Spencer Pharmaceutical (CE) (USOTC:SPPH)
過去 株価チャート
から 5 2024 まで 6 2024
Spencer Pharmaceutical (CE) (USOTC:SPPH)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Spencer Pharmaceutical Inc (CE) (その他OTC): 0 recent articles
その他のSpencer Pharmaceutical Inc.ニュース記事